215 related articles for article (PubMed ID: 20085772)
21. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
Mahasa KJ; de Pillis L; Ouifki R; Eladdadi A; Maini P; Yoon AR; Yun CO
Sci Rep; 2020 Jan; 10(1):425. PubMed ID: 31949228
[TBL] [Abstract][Full Text] [Related]
22. Fighting Cancer with Mathematics and Viruses.
Santiago DN; Heidbuechel JPW; Kandell WM; Walker R; Djeu J; Engeland CE; Abate-Daga D; Enderling H
Viruses; 2017 Aug; 9(9):. PubMed ID: 28832539
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic Virotherapy by HSV.
Watanabe D; Goshima F
Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
[TBL] [Abstract][Full Text] [Related]
24. Going viral: a review of replication-selective oncolytic adenoviruses.
Larson C; Oronsky B; Scicinski J; Fanger GR; Stirn M; Oronsky A; Reid TR
Oncotarget; 2015 Aug; 6(24):19976-89. PubMed ID: 26280277
[TBL] [Abstract][Full Text] [Related]
25. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
26. Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy: a mathematical model.
Kim Y; Lee HG; Dmitrieva N; Kim J; Kaur B; Friedman A
PLoS One; 2014; 9(7):e102499. PubMed ID: 25047810
[TBL] [Abstract][Full Text] [Related]
27. Next-generation oncolytic vaccinia vectors.
Thorne SH
Methods Mol Biol; 2012; 797():205-15. PubMed ID: 21948478
[TBL] [Abstract][Full Text] [Related]
28. The use of the NIS reporter gene for optimizing oncolytic virotherapy.
Miller A; Russell SJ
Expert Opin Biol Ther; 2016; 16(1):15-32. PubMed ID: 26457362
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in oncolytic adenovirus therapies for cancer.
Rosewell Shaw A; Suzuki M
Curr Opin Virol; 2016 Dec; 21():9-15. PubMed ID: 27379906
[TBL] [Abstract][Full Text] [Related]
30. Integrating oncolytic viruses in combination cancer immunotherapy.
Bommareddy PK; Shettigar M; Kaufman HL
Nat Rev Immunol; 2018 Aug; 18(8):498-513. PubMed ID: 29743717
[TBL] [Abstract][Full Text] [Related]
31. Mathematical Modelling of the Interaction Between Cancer Cells and an Oncolytic Virus: Insights into the Effects of Treatment Protocols.
Jenner AL; Yun CO; Kim PS; Coster ACF
Bull Math Biol; 2018 Jun; 80(6):1615-1629. PubMed ID: 29644518
[TBL] [Abstract][Full Text] [Related]
32. ReVOLT: radiation-enhanced viral oncolytic therapy.
Advani SJ; Mezhir JJ; Roizman B; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):637-46. PubMed ID: 17011442
[TBL] [Abstract][Full Text] [Related]
33. Design of virotherapy for effective tumor treatment.
Garcia-Aragoncillo E; Hernandez-Alcoceba R
Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
[TBL] [Abstract][Full Text] [Related]
34. Multiscale moving boundary modelling of cancer interactions with a fusogenic oncolytic virus: The impact of syncytia dynamics.
Alzahrani T; Eftimie R; Trucu D
Math Biosci; 2020 May; 323():108296. PubMed ID: 31887267
[TBL] [Abstract][Full Text] [Related]
35. Oscillations in a Spatial Oncolytic Virus Model.
Baabdulla AA; Hillen T
Bull Math Biol; 2024 Jun; 86(8):93. PubMed ID: 38896363
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic herpes simplex virus treatment of metastatic breast cancer.
Wang J; Hu P; Zeng M; Rabkin SD; Liu R
Int J Oncol; 2012 Mar; 40(3):757-63. PubMed ID: 22108767
[TBL] [Abstract][Full Text] [Related]
37. A mathematical model for cell cycle-specific cancer virotherapy.
Crivelli JJ; Földes J; Kim PS; Wares JR
J Biol Dyn; 2012; 6 Suppl 1():104-20. PubMed ID: 22873678
[TBL] [Abstract][Full Text] [Related]
38. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
Kapadia R; Coffey MC
Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
[TBL] [Abstract][Full Text] [Related]
39. Editorial overview: Oncolytic viruses--replicating virus therapeutics for the treatment of cancer.
Bell JC; McFadden G
Curr Opin Virol; 2015 Aug; 13():viii-ix. PubMed ID: 26260227
[No Abstract] [Full Text] [Related]
40. Current issues and future directions of oncolytic adenoviruses.
Yamamoto M; Curiel DT
Mol Ther; 2010 Feb; 18(2):243-50. PubMed ID: 19935777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
